It is straight forward really,
NNZ 2591 for RETT and Fragile X world wide is owned by ACADIA and pay royalties to Neuren.
NNZ2591 used for other diseases such as THE CURRENT 4 TRIALS NEU are doing will be owned exclusively by NEU.
BP van take over Neuren and have world rights to NNZ 2591 and recieve royalties from ACADIA for Rett Syndrome/ Daybue sales and fragile X when that eventuates.
- Forums
- ASX - By Stock
- NEU
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-139
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.60 |
Change
-0.340(2.13%) |
Mkt cap ! $1.993B |
Open | High | Low | Value | Volume |
$16.25 | $16.32 | $15.55 | $9.440M | 595.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 3197 | $15.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.68 | 1852 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 295 | 16.750 |
2 | 2317 | 16.380 |
1 | 95 | 16.100 |
1 | 2309 | 16.000 |
1 | 22 | 15.880 |
Price($) | Vol. | No. |
---|---|---|
15.520 | 234 | 2 |
15.550 | 118 | 1 |
15.700 | 30 | 1 |
15.730 | 1000 | 1 |
15.800 | 349 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |